These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16340402)

  • 1. Epidemiology of the diabetic heart.
    Tziakas DN; Chalikias GK; Kaski JC
    Coron Artery Dis; 2005 Nov; 16 Suppl 1():S3-S10. PubMed ID: 16340402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic syndrome in patients with diabetes mellitus type 1, prevalence, impact on morbidity and mortality].
    Brožová J; Čechurová D; Lacigová S
    Vnitr Lek; 2016; 62(11 Suppl 4):S8-14. PubMed ID: 27921419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure and diabetes mellitus: epidemiology and management of an alarming association.
    Cohen-Solal A; Beauvais F; Logeart D
    J Card Fail; 2008 Sep; 14(7):615-25. PubMed ID: 18722328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which factor is the most effective one in metabolic Sydrome on the outcomes after coronary artery bypass graft surgery? A cohort study of 5 Years.
    Wang L; Qian X; Wang M; Tang X; Ao H
    J Cardiothorac Surg; 2018 Jan; 13(1):1. PubMed ID: 29301583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II and the cardiac complications of diabetes mellitus.
    Connelly KA; Boyle AJ; Kelly DJ
    Curr Pharm Des; 2007; 13(26):2721-9. PubMed ID: 17897016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.
    Unwin N; Shaw J; Zimmet P; Alberti KG
    Diabet Med; 2002 Sep; 19(9):708-23. PubMed ID: 12207806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome influencing infarct size and heart failure in patients with acute coronary syndrome: does gender matter?
    Kranjcec D; Altabas V
    Endocr J; 2012; 59(12):1065-76. PubMed ID: 22971940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of diabetes mellitus and associated cardiovascular risk factors: focus on human immunodeficiency virus and psychiatric disorders.
    Zimmet P
    Am J Med; 2005 Apr; 118 Suppl 2():3S-8S. PubMed ID: 15903289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population.
    Gupta A; Gupta R; Sarna M; Rastogi S; Gupta VP; Kothari K
    Diabetes Res Clin Pract; 2003 Jul; 61(1):69-76. PubMed ID: 12849925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic syndrome and prediabetic states].
    Galajda P; Mokáň M; Mokáň M
    Vnitr Lek; 2013 Jun; 59(6):453-8. PubMed ID: 23808738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The patient with diabetes mellitus and heart failure: at-risk issues.
    Giles TD
    Am J Med; 2003 Dec; 115 Suppl 8A():107S-110S. PubMed ID: 14678875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
    Petersen JL; McGuire DK
    Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival: The Cardiovascular Disease Lifetime Risk Pooling Project.
    Ahmad FS; Ning H; Rich JD; Yancy CW; Lloyd-Jones DM; Wilkins JT
    JACC Heart Fail; 2016 Dec; 4(12):911-919. PubMed ID: 27908389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New clinical data with metformin therapy in patients with diabetes mellitus].
    Jermendy G
    Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.
    Lorenzo C; Okoloise M; Williams K; Stern MP; Haffner SM;
    Diabetes Care; 2003 Nov; 26(11):3153-9. PubMed ID: 14578254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Bozkurt B; Aguilar D; Deswal A; Dunbar SB; Francis GS; Horwich T; Jessup M; Kosiborod M; Pritchett AM; Ramasubbu K; Rosendorff C; Yancy C;
    Circulation; 2016 Dec; 134(23):e535-e578. PubMed ID: 27799274
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer.
    Gallagher EJ; LeRoith D
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S233-9. PubMed ID: 23882051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.